Postmenopausal breast cancer, androgens, and aromatase inhibitors.
about
Risk-reducing medication for primary breast cancer: a network meta-analysisAndrogen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified?17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1Alcohol Consumption and Risk of Breast Cancer by Tumor Receptor Expression.Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response.
P2860
Postmenopausal breast cancer, androgens, and aromatase inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Postmenopausal breast cancer, androgens, and aromatase inhibitors.
@en
type
label
Postmenopausal breast cancer, androgens, and aromatase inhibitors.
@en
prefLabel
Postmenopausal breast cancer, androgens, and aromatase inhibitors.
@en
P2093
P2860
P50
P1476
Postmenopausal breast cancer, androgens, and aromatase inhibitors
@en
P2093
P2860
P2888
P356
10.1007/S10549-013-2505-2
P407
P577
2013-04-10T00:00:00Z
P6179
1042432432